Plavix Makers Ordered to Pay Hawaii $834 Million For Alleged ‘Deceptive’ Acts



DOCUMENTS
  • Opinion


HONOLULU — A Hawaii judge has ordered two drug makers to pay the state $834 million for allegedly failing to disclose that their blood-thinning drug Plavix is ineffective in reducing the risk of strokes, blood clots and heart attacks in patients of Asian and Pacific Islander descent.

Bristol-Myers Squibb and Sanofi say they will appeal the ruling, which was issued on Feb. 15 by Hawaii First Circuit Court Judge Dean E. Ochiai following a four-week bench trial that ended on Nov. 20. The drug makers were each ordered to pay $417 million in penalties.

The judge found that the …






UPCOMING CONFERENCES




HarrisMartin's Webinar Series: Natural Disaster Litigation - Insurance and Beyond - Winter Storm Uri and Hurricane Sally

March 09, 2021 - Haddonfield, NJ
HarrisMartin Webinar Series

MORE DETAILS



HarrisMartin's Webinar Series: The Elmiron MDL - Hear from the Leadership Counsel

March 05, 2021 - Haddonfield, NJ
HarrisMartin Webinar Series

MORE DETAILS